ETHEREUM… WTF IS WRONG WITH TOM LEE???
1 extracted signal · 0 resolved · 1 still active
Lark DavisIndependent analyst profile- Source published
- 12 Sept 2026, 12:00 UTC
- Recorded by Tahlil Plus
- 12 Sept 2026, 15:40 UTC

AI-generated source summary
The video discusses Ethereum (ETHUSD) on a weekly chart, highlighting historical price action around the 200-week Exponential Moving Average (EMA). Previous instances of breaking above the 200-week EMA have led to significant upward price movements (e.g., 162% in May 2025 and a 6-month to 1-year rally before a weekly MACD bear cross in January 2023). The analysis suggests that while the MACD is currently showing a bullish crossover, the price is consolidating around the 200-week EMA, facing resistance near $2550-$2564. The potential for volatility is noted, with past examples showing sharp pumps followed by significant dumps, but the underlying trend remains bullish as long as the price stays above key support levels. The update to Ethereum's layer 2 scaling solutions, such as the EIP-8141 upgrade, is mentioned as a potential positive fundamental catalyst for future adoption and price appreciation, targeting full quantum resistance by December 2029.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Lark Davis
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
